Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Refinancing

1 Oct 2013 09:58

RNS Number : 3878P
Derwent London PLC
01 October 2013
 



1 October 2013

 

Derwent London signs new £550m five year unsecured bank facility

 

Derwent London ("Derwent London plc"/ "the Group") announces today that it has signed a new £550m unsecured five year revolving credit facility.

 

The new facility is being provided by the Group's principal relationship banks, HSBC, RBS, Barclays and Lloyds, with HSBC as agent. It replaces £650m of secured bank facilities expiring between April 2014 and January 2017, as was indicated in the Group's interim results announced in August and follows on from the Group's issue in July of £150m of convertible bonds due in July 2019.

 

The margin payable under the new facility is 160 basis points over LIBOR for net asset gearing levels of up to 50%. The margin increases at higher levels of gearing with a maximum permitted level of 160%. The current level of Group net asset gearing is 40.4% based on June 2013 property values.

 

Damian Wisniewski, Finance Director of Derwent London, commented:

 

"Our new unsecured bank facility brings greater operational flexibility in relation to individual properties and the release of security on the facilities repaid provides the Group with a pool of unencumbered assets of over £1.8bn. We are pleased to have put these new arrangements in place at competitive pricing."

 

-ends-

 

 

For further information please contact:

 

Derwent London 020 7659 3000

 

Damian Wisniewski, Finance Director

 

Louise Rich, Head of Investor Relations

 

 

Brunswick Group 020 7404 5959

 

Elizabeth Adams

 

Sheena Shah

 

 

 

Notes to editors

 

Derwent London

 

Derwent London plc owns a portfolio of commercial real estate predominantly in central London valued at £3.1bn as at 30 June 2013, making us the largest London-focused real estate investment trust (REIT).

Our experienced team has a proven record of value creation through development, refurbishment and asset management activities. We take a fresh approach to each building, adopting a design-led and tenant-led philosophy. We focus on buildings with reversionary mid-market rents, particularly those in improving locations around the West End and the City borders.

The business is grounded on a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Landmark schemes in our portfolio of 5.5 million sq ft (510,600m2) as at 30 June 2013 include Angel Building EC1, The Buckley Building EC1, Qube W1, Horseferry House SW1 and Tea Building E1.

In 2013 to date Derwent London has won the 'West End Deal of the Year' for our letting to Burberry at 1 Page Street SW1 and 'City Development of the Year' for our 4 & 10 Pentonville Road N1 scheme at the OAS Development Awards as well as 'Developer of the Year' at the New Energy & Cleantech Awards. In addition the 2012 Report & Accounts and 2012 Sustainability Report have been awarded an EPRA Gold award

Derwent London came seventh overall in the 2012 Management Today awards for 'Britain's Most Admired Companies', topping the real estate sector for the third year in a row. Earlier in 2012 the Group won the Estates Gazette 'Property Company of the Year - Offices' award. Last year the Tea Building also won a RIBA regional award and an AJ Retrofit award for the 'Green Tea' refurbishment to improve the environmental performance of the building.

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPEFESKDFEF
Date   Source Headline
28th Feb 20237:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
31st Jan 202311:30 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSDirector Declaration
20th Jan 20232:50 pmRNSHolding(s) in Company
19th Jan 20232:30 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSSale of 19 Charterhouse Street EC1
30th Dec 20221:15 pmRNSTotal Voting Rights
6th Dec 20224:00 pmRNSHolding(s) in Company
30th Nov 20224:30 pmRNSTotal Voting Rights
16th Nov 202212:15 pmRNSHolding(s) in Company
3rd Nov 20227:00 amRNSThird Quarter Business Update
31st Oct 20224:45 pmRNSTotal Voting Rights
19th Oct 20223:31 pmRNSDirector/PDMR Shareholding
13th Oct 20225:20 pmRNSHolding(s) in Company
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:45 pmRNSTotal Voting Rights
21st Sep 20225:00 pmRNSDirector/PDMR Shareholding
20th Sep 20224:30 pmRNSBlock listing Interim Review
31st Aug 20224:45 pmRNSTotal Voting Rights
25th Aug 20229:15 amRNSAdditional Listing
17th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202210:30 amRNSHolding(s) in Company
11th Aug 20227:00 amRNSUnaudited Results for six months ended 30.06.22
10th Aug 20224:30 pmRNSHolding(s) in Company
2nd Aug 20223:45 pmRNSHolding(s) in Company
29th Jul 20224:45 pmRNSTotal Voting Rights
26th Jul 20225:15 pmRNSHolding(s) in Company
21st Jul 20223:00 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSDisposal of Bush House WC2
30th Jun 20224:45 pmRNSTotal Voting Rights
9th Jun 202210:00 amRNSAdditional Listing
6th Jun 20222:00 pmRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSTotal Voting Rights
26th May 20223:10 pmRNSHolding(s) in Company
24th May 20225:10 pmRNSHolding(s) in Company
13th May 20221:00 pmRNSResult of AGM
10th May 20229:00 amRNSBondholders' Meeting
5th May 20227:01 amRNSCity Road Island EC1 Exchange of Contract
5th May 20227:00 amRNSQ1 2022 Business Update
29th Apr 20224:45 pmRNSTotal Voting Rights
13th Apr 20222:00 pmRNSReport and Accounts 2021 and Notice of AGM
31st Mar 20224:45 pmRNSTotal Voting Rights
22nd Mar 20229:00 amRNSBlock listing Interim Review replacement
21st Mar 20226:10 pmRNSBlock listing Interim Review
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
10th Mar 20222:00 pmRNSDirector/PDMR Shareholding
10th Mar 202210:00 amRNSAdditional Listing
2nd Mar 20229:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.